News and Comments

Biotechnology Companies: A Model that’s Gaining Visibility

  Tuesday, December 07, 2010

The biotechnology company model founded on management skills rather than purely on scientific skills has begun to gain investors’ appreciation. The reason is that many firms built around skilled, experienced entrepreneurs have succeeded in bringing a large number of drugs to the market and in marketing them competently. These firms license or acquire drugs in mid-or late-phase trials. They sometimes acquire therapeutic molecules in early-stage development only if these molecules prove to have optimal affinity on validated proteins in pathways of diseases, and produce desired agonist or antagonist effects. In order to select the products that can be called breakthroughs, the most successful of the firms established and run by entrepreneurs with strong business acumen employ specialists in pharmaceutical sciences and in clinical trials. These scientists have experience in sensitive areas such as drug development, clinical trials, medicinal chemistry, and other important disciplines required for drug discovery, development and testing.   More...

Recent Postings



INNOVIVA (INVA) Dynavax (DVAX) HALOZYME (HALO) ZALTRAP™ AstraZeneca (AZN) Rapamune TOKAI (TKAOI) Intercept (ICPT) Velcade (bortezomib) PTC Therapeutics (PTCT) CompuGen (CGEN) Onyx (ONXX) Epizyme (EPZM) Alnylam (ALNY) Illumina (ILMN) LEXICON (LXRX) Prosensa (RNA) Dendreon (DNDN) Abbott Laboratories (ABT) Elan (ELN) Micromet (MITI) Editas (EDIT) CEMPRA (CEMP) Xoma (XOMA) galapagos (GLPG) KITE (KITE) Ariad (ARIA) IDERA (IDRA) Genentech Ziofpharm (ZIOP) Bristol-Myers Squibb (BMY) Cytokinetics (CYTK) ABBVIE (ABBV) SYNTA (SNTA) C4 Therapeutics Endometrial Cancer Ionis (IONS) Sanofi (SNY) CRISPR Therapeutics (CRSP) GlycoMimetics (GLYN) Roche (ROCHE) Merck (MRK) KERYX (KERX) Gilead (GILD) Incyte (INCY) Sarepta (SRPT) Ridaforolimus ImmunoGen (IMGN) VANDA (VNDA) Exelixis (EXEL) Herceptin ACADIA (ACAD) Array Pharmaceuticals (ARRY) Roche (RHHBY) NEKTAR (NKTR)) Biocryst (BCRX) Anadys (ANDS) Multiple Myeloma OSI (OSIP) Advaxis (ADXS) Vertex (VRTX) Global Cell Therapeutics (GBT) Idenix (IDIX) OncoCyte (OCX) Agenus (AGEN ADVENTRIX (ANX) AGOS (ARGS) ARGOS (ARGS) Zerenex Valeant Pharmaceuticals International (VRX) Telaprevir Revlimid (lenolidamide) Theravance (THRX) Akebia Therapeutics (AKAB) JUNO (JUNO) BIOMARIN (BMRN) Mirati Therapeutics (MRTX) Aimmune Therapeutics (AIMT) GUARDIAN HEALTH Galena (GALE) Vitae Pharmaceuticals (VTAE) ARCA (ABIO) REGULUS (RGLS) Seattle Genetics (SGEN) Adaptimmune (ADAP) Agenus (AGEN) Jazz Pharmaceuticals (JAZZ) Sanofi (SNA) Bellicum (BLCM) Sangamo (SGMO) SUNESIS PHARMACEUTICALS (SNSS) Pluristem (PSTI) Human Longevity (HLI) Sanofi-Aventis (SAN) Amgen (AMGN) ISIS (ISIS) RenenxBio (RGNX) NOVOCURE (NVCR) Human Genome Sciences (HGSI) Tysabri AERIE PHARMACEUTICALS Intermune (ITMN) Benlysta (belimumab) Prolor Biotech (PBTH) Auspex (ASPX) SERES THERAPEUTICS (MCRB) GlaxoSmithKline (GSK) Anacor (ANAC) Trastuzumab-DM1 Intrexon (XON) Alder Biopharmaceuticals (ALDR) Theravance Bio Pharma (TBPH) MODERNA Biogen Idec (BIIB) NANTKWEST (NK) JOUNCE THERAPEUTICS (JNCE) Ocular Therapeutix (OCUL) NEUROCRINE (NBIX) Regeneron (REGN) Spike Therapeutics (ONCE) PORTOLA (PTLA) Inovio (INO) Sequenom (SQNM)